We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 161.50
Bid: 161.00
Ask: 161.50
Change: -0.25 (-0.15%)
Spread: 0.50 (0.311%)
Open: 161.50
High: 161.50
Low: 161.50
Prev. Close: 161.50
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

26 Jan 2023 07:00

RNS Number : 8629N
TClarke PLC
26 January 2023
 

 

26 January 2023

TClarke plc

 

YEAR END TRADING UPDATE

 

NOTICE OF RESULTS

 

Record revenues achieved in 2022

 

TClarke plc ("TClarke" or the "Group"), the Building Services Group, today announces a year end trading update for the full year ended 31 December 2022 ("FY2022").

 

Financial Results

 

The Board is pleased to report that trading in the second half of the year has continued strongly and that the Group's financial performance for the full year is in line with market expectations.

 

The Group anticipates reporting turnover for FY2022 of c.£425m and earnings before interest and tax (EBIT) of c.£11.5m. FY2022 profit before tax is expected to be c.£10.3m (FY2021: £7.8m). Revenue has increased by almost £100m (or 30%) compared to FY2021 and earnings per share are anticipated to rise by approximately 30% over FY2021 levels as a result.

 

Order Book Record

 

TClarke occupies a premier position in the marketplace, particularly in London. The Group has invested heavily in resources and capacity, ensuring that the Group's growth ambitions are fully supported, and our clients' projects continue to be delivered on time. Our order book has now increased to £555m (2021: £534m).

Cash Performance

 

Cash at the year-end was £22.5m (2021: £20.3m) with £15m (2021: £15m) drawn down on the Group's revolving credit facility. Net cash was therefore £7.5m and our average month end net cash during FY2022 was £2.6m. As at 31 December 2022 the Group has a further £10m of revolving credit facility and an overdraft facility of £5m available to it. Bank facilities are committed until 31 August 2026. 

Balance Sheet

Building on our existing balance sheet strength is another key part of our strategy as we grow the business. Net assets of the Group are expected have grown by c.40% during 2022 and now amount to c.£38m.

Outlook

 

Looking to the future, TClarke is focused on delivering its growth strategy. The Group is expecting to achieve its target turnover of £500m in 2023. The size of the existing order book and the number of opportunities ahead for the Group supports the expectation that TClarke will achieve its targets.

 

The Group's growth strategy is focused on maintaining and developing our core markets whilst significantly expanding our data centre business. The Group is also undertaking more large projects outside of London, expanding its healthcare offering and energy efficient smart building solutions.

 

Commenting, Mark Lawrence, TClarke CEO said:

 

''TClarke has had a tremendous year delivering a record level of turnover for the period and ending the year with an order book at a level that supports our £500m turnover target. We are on track to achieve our growth ambitions and I am extremely excited and confident for the outlook for TClarke.''

The Group will be announcing its FY2022 preliminary results on 8 March 2023.

 

-ends-

 

For further information contact:

 

TClarke plc

Mark Lawrence, Group Chief Executive 

Trevor Mitchell, Finance Director

Tel: 020 7997 7400

 www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

Ben Jeynes (Corporate Finance)

Alex Pollen (Sales)

Tel: 020 7397 8900

 www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUCPGUPWGPA
Date   Source Headline
26th Apr 20241:28 pmPRNForm 8.3 - TClarke Plc
26th Apr 202410:09 amRNSForm 8.5 (EPT/NON-RI) - TClarke PLC
25th Apr 20241:56 pmPRNForm 8.3 - TClarke Plc
25th Apr 202411:52 amRNSForm 8.3 - TClarke PLC
25th Apr 20249:18 amRNSForm 8 (OPD) - TClarke plc
24th Apr 20247:21 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20242:58 pmPRNForm 8.3 - TClarke Plc
19th Apr 20241:21 pmPRNForm 8.3 - TClarke Plc
18th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
18th Apr 20247:00 amRNSForm 8.1: Regent Acquisitions Limited
17th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
17th Apr 20243:03 pmGNWForm 8.3 - [TCLARKE PLC - 16 04 2024] - (CGAML)
17th Apr 202412:57 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - Opening Position Disclosure Re: Clarke (T.) PLC
17th Apr 20249:47 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 20244:36 pmRNSWider Regent Group Interests in TClarke Shares
16th Apr 20247:00 amRNSRevised Dividend Timetable
16th Apr 20247:00 amRNSRecommended Cash Acquisition of TClarke plc
9th Apr 20241:41 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:34 pmRNSTR-1 Notification of Holdings
27th Mar 20242:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSFinal Results
4th Jan 20247:00 amRNSBlock listing Interim Review
30th Nov 20237:00 amRNSTrading Update
24th Oct 202310:21 amRNSChange of Corporate Broker
27th Jul 20234:24 pmRNSTR-1: Notification of Change of Holding
24th Jul 20235:43 pmRNSUpdate on Admission
24th Jul 20233:32 pmRNSTR-1: Notification of Change of Holding
24th Jul 202311:48 amRNSResult of GM & Total Voting Rights
13th Jul 20231:23 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSHalf-year Report
6th Jul 20237:00 amRNSPlacing and Notice of GM
6th Jul 20237:00 amRNSTrading Statement
4th Jul 20237:00 amRNSBlock listing Interim Review
10th May 202311:31 amRNSResult of AGM
10th May 20237:00 amRNSAGM Trading Update
12th Apr 202311:15 amRNSNotice of AGM
27th Mar 202310:26 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTClarke - Preliminary Results
31st Jan 20237:00 amRNSNotice of Investor Presentation
26th Jan 20237:00 amRNSTrading Statement
4th Jan 202312:09 pmRNSBlock listing Interim Review
24th Nov 20227:00 amRNSTrading Statement
1st Nov 20225:13 pmRNSESOT Share Purchase
25th Oct 20222:14 pmRNSESOT Share Purchase
18th Jul 20227:00 amRNSInvestor Presentation
14th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:12 pmRNSBlock listing 6 Monthly Return
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.